Operating Expenses
Operating Lease Cost
Vertex Pharmaceuticals Operating Lease Cost remained flat by 0.0% to $48.68M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 87.4%, from $25.98M to $48.68M. Over 2 years (FY 2023 to FY 2025), Operating Lease Cost shows an upward trend with a 101.8% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
Metric ID:
ms_operating_lease_costHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $47.80M | $103.90M | $194.70M |
| YoY Change | — | +117.4% | +87.4% |
Range$47.80M – $194.70M
CAGR+101.8%
Avg YoY Growth+102.4%
Median YoY Growth+102.4%
Current Streak2+ years growth
Operating Lease Cost at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's operating lease cost?
- Vertex Pharmaceuticals (VRTX) reported operating lease cost of $48.68M in Q4 2025.
- How has Vertex Pharmaceuticals's operating lease cost changed year-over-year?
- Vertex Pharmaceuticals's operating lease cost increased by 87.4% year-over-year, from $25.98M to $48.68M.
- What is the long-term trend for Vertex Pharmaceuticals's operating lease cost?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's operating lease cost has grown at a 101.8% compound annual growth rate (CAGR), from $47.80M to $194.70M.